Psychedelics – News and Features
News
Sensitive Pediatric Pharmacology Assays for HIV Drugs Developed by Vitalea Science
Vitalea recieves NIAID grant to develop and test assays that can be applied to children and neonates to quantify intracellular uptake of antiretroviral drugs.
News
Vitalea Science Announces Grant Award to Develop a Diagnostic Test Using MS Technologies
The Company receives SBIR grant to develop a medical diagnostic test to assess vitamin B12 malabsorption.
News
Accium BioSciences and CMIC Announce Strategic Alliance
Accium and CMIC Co. to offer Exploratory-IND (microdosing) and low-radiation PK/ADME clinical trials services to Japan pharmaceutical clients.
News
Xceleron Executes Microdose Agreement with Resverlogix
The study’s purpose is to administer sub-pharmacological dose levels of promising drug candidates in human volunteers.
News
Xcelleron Sign Agreement with Biofrontera
Companies collaborate to accelerate drug development using microdosing.
News
Xceleron Receives the Award for International Achievement at Yorkshire Bioscience Awards
Xceleron was recognized for its recent achievements overseas following the establishment of its subsidiary in the US.
News
Xceleron Leads EU Microdose AMS Partnership Programme
The programme aims to certify AMS technologies as appropriate methodologies for measurements required by microdosing studies.
News
Xceleron and Servier Sign Agreement to Accelerate Drug Development
The Agreement covers the provision by Xceleron of accelerator mass spectrometry services to assist Servier.
News
Xceleron Signs Three Year Preferred Supplier Agreement With GSK
Xceleron will provide support for GSK's bioanalytical AMS programme.
Advertisement
